China-based medical diagnostics technology developer Shukun Technology has raised RMB200m ($29.2m) from investors including mobile software producer ThunderSoft, China Money Network reported yesterday.
Venture capital firm Qiming Venture Partners led the round, which also featured Everest Capital and SPD Silicon Valley Bank.
Shukun has created smart imaging systems that use artificial intelligence to diagnose cardiovascular diseases. It launched a similar product for the diagnosis of strokes in July this year.
The company raised about $3m from Marathon Venture Partners in 2017, adding roughly $15m in a 2018 series A round co-led by Huagai Capital and Morningside Venture Capital, according to China Money Network.
Financial services firm BOC International led Shukun’s $28.3m series B1 round in June this year, investing together with China Construction Bank’s CCB International Healthcare Fund, Huagai Capital and China Creation Ventures, which was also identified as an existing backer.
